Targeted contrast agents for magnetic resonance imaging and ultrasound
Top Cited Papers
- 1 February 2005
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 16 (1) , 89-92
- https://doi.org/10.1016/j.copbio.2004.11.001
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Quantitative “magnetic resonance immunohistochemistry” with ligand‐targeted 19F nanoparticlesMagnetic Resonance in Medicine, 2004
- In Vivo Magnetic Resonance Imaging of Coronary Thrombosis Using a Fibrin-Binding Molecular Magnetic Resonance Contrast AgentCirculation, 2004
- MR molecular imaging of early endothelial activation in focal ischemiaAnnals of Neurology, 2004
- Improved route for the visualization of stem cells labeled with a Gd‐/Eu‐Chelate as dual (MRI and fluorescence) agentMagnetic Resonance in Medicine, 2004
- Glucose-Receptor MR Imaging of Tumors: Study in Mice with PEGylated Paramagnetic NiosomesRadiology, 2004
- Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRIMagnetic Resonance in Medicine, 2004
- Synthesis and Physicochemical Characterization of Gd−DTPA−B(sLex)A, a New MRI Contrast Agent Targeted to InflammationBioconjugate Chemistry, 2003
- Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With α v β 3 -Integrin–Targeted NanoparticlesCirculation, 2003
- Improved molecular imaging contrast agent for detection of human thrombusMagnetic Resonance in Medicine, 2003
- MR molecular imaging of the Her‐2/neu receptor in breast cancer cells using targeted iron oxide nanoparticlesMagnetic Resonance in Medicine, 2003